Shortage of top anti-anxiety drug could cause suffering, doctors warn

A third of the country's buprisone supply has been cut off after an FDA inspection of a Mylan factory in West Virginia, which produces the drug, found it to be dirty and failing in quality.

Source: the Mail online | Health - February 1, 2019 Category: Consumer Health News Source Type: news